FDA Inspection
Csl PlasmaCsl Plasma – FDA Inspection, Aug 30, 2012
Record Details
This FDA Inspection record concerns Csl Plasma, with an inspection on August 30, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Csl Plasma
- Inspection Date
- August 30, 2012
- Product Type
- Biologics
View Company Profile
ID · 5d7f7cc2-2ce3-4ad9-9800-98ef65a3df4b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 796054
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Csl Plasma
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 18, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 30, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 11, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 9, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 16, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Csl Plasma
- FDA Inspection 1165187 - 2022-03-18
- FDA Inspection 998482 - 2017-01-30
- FDA Inspection 894401 - 2014-09-11
- FDA Inspection 669759 - 2010-07-09
- FDA Inspection 654618 - 2010-03-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.